Site icon OncologyTube

Key Points from the Adaura Trial: Osimertinib – Targeted Therapies in Lung Cancer 2023

Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q&A with the audience, as well as a presentation by a patient advocate, Ivy Elkins.

In this video, Dr. Joshua Reuss examines important details learned during the ADAURA trial, including overall survival, reduced risk of brain mets, and side effects.

For more, please visit http://cancerGRACE.org/.
To join the conversation, visit https://cancergrace.org/forum.

BenSound File Name: Sweet (BenSound.com)
BenSound License #: DSSHUIYGV4VQCETM

Thank you to our sponsors: Takeda, Janssen , Lilly, Genentech , Mirati, Exact Sciences, BMS, and GE Healthcare.

Exit mobile version